Immatics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immatics and other ETFs, options, and stocks.

About IMTX

Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline include adoptive cell therapy and TCR Bispecifics.The company was founded on March 10, 2020 and is headquartered in Tuebingen, Germany. 

CEO
Harpreet Singh-Jasuja
CEOHarpreet Singh-Jasuja
Employees
255
Employees255
Headquarters
Tuebingen, Baden Wuerttemberg
HeadquartersTuebingen, Baden Wuerttemberg
Founded
2000
Founded2000
Employees
255
Employees255

IMTX Key Statistics

Market cap
586.84M
Market cap586.84M
Price-Earnings ratio
18.73
Price-Earnings ratio18.73
Dividend yield
Dividend yield
Average volume
273.68K
Average volume273.68K
High today
$9.10
High today$9.10
Low today
$8.76
Low today$8.76
Open price
$8.93
Open price$8.93
Volume
187.01K
Volume187.01K
52 Week high
$14.90
52 Week high$14.90
52 Week low
$5.75
52 Week low$5.75

IMTX Earnings

-$0.54
$0.27
$1.07
$1.88
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 15, Pre-Market
ActualExpected Nov 15, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.